A 3-in-1 mode of action kills bacteria, manages exudate, and debrides the wound bed.
As IODOSORB Gel contains 0.9% w/w iodine it should not be used in patients with known or suspected Iodine sensitivity. IODOSORB Gel is contraindicated in Hashimoto's Thyroiditis.
In patients with a prior history of Graves Disease it is not recommended to use iodine containing products, which includes IODOSORB Gel.
The gel should not be used in the case of non-toxic nodular goitre. Patients with a past history of any thyroid disorder are more susceptible to alteration in thyroid metabolism with chronic IODOSORB therapy.
Iodine is absorbed systemically especially when large wounds are treated.
In endemic goitre there has been isolated reports of hyperthyroidism associated with IODOSORB.
There is a potential for interaction of iodine with the following drugs and therefore co-administration is not recommended, Lithium, Sulphafurazoles and Sulphonylureas.
It has been observed occasionally that an adherent crust can form when the dressing is not changed with significant frequency.
Iodine can cross the placental barrier and is secreted into milk. Do not use IODOSORB◊ in pregnant or lactating women.